Co-Diagnostics, Inc. to Host Booth at 67th Annual CARPHA Conference April 27-29

Rhea-AI Summary

Co-Diagnostics, Inc. (Nasdaq: CODX) will host a booth at the 67th Annual Health Research Conference organized by the Caribbean Public Health Agency (CARPHA), taking place from April 27-29, 2023, in the Bahamas. This conference is the largest and longest-running health research event in the Caribbean and Latin America, aimed at promoting collaboration among health scientists and policymakers.

Co-Diagnostics will showcase its infectious disease products, including the upcoming Co-Dx PCR Home™ testing platform, which is currently under FDA review and not yet available for sale. The company has actively participated in CARPHA conferences since 2016 and is well-regarded for its innovative diagnostics technologies.

SALT LAKE CITY, April 26, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth at the Caribbean Public Health Agency (CARPHA) 67^th Annual Health Research Conference, being held in-person April 27-29, 2023, in the Bahamas.

The CARPHA Annual Health Research Conference is the largest health research conference in the English-speaking Caribbean and the longest-running health research Conference in Latin America and the Caribbean region, with the goal of facilitating and promoting communication and sharing of scientific outputs among health scientists, policymakers, and related professionals in the wider Caribbean Region.

The Company's booth will showcase Co-Diagnostics' infectious disease and vector control products to conference attendees, along with its upcoming Co-Dx PCR Home™ testing platform*. Co-Dx has had several important relationships in the Caribbean basin and has regularly attended the annual CARPHA conference since 2016.

More information about the conference may be found here. Attendees interested in learning more about the Company and its products, including its upcoming Co-Dx PCR Home platform, are invited to visit the Company's booth.

*The Co-Dx PCR Home platform is subject to FDA review and is not available for sale.

About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR Home™ platform and to locate genetic markers for use in applications other than infectious disease.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-host-booth-at-67th-annual-carpha-conference-april-27-29-301807986.html

SOURCE Co-Diagnostics

FAQ

What is Co-Diagnostics planning at the CARPHA conference 2023?

Co-Diagnostics, Inc. will host a booth at the CARPHA conference from April 27-29, 2023, to showcase its infectious disease and vector control products.

When is the CARPHA 67th Annual Health Research Conference held?

The CARPHA 67th Annual Health Research Conference is being held from April 27-29, 2023.

Where is the CARPHA conference taking place?

The CARPHA conference is taking place in the Bahamas.

What products will Co-Diagnostics showcase at the conference?

Co-Diagnostics will showcase its infectious disease products and the upcoming Co-Dx PCR Home™ testing platform.

Is the Co-Dx PCR Home testing platform available for sale?

No, the Co-Dx PCR Home testing platform is subject to FDA review and is not available for sale.

Why is the CARPHA conference significant?

The CARPHA conference is the largest health research conference in the Caribbean and aims to facilitate communication among health scientists and policymakers.